Ann: Change of Director's Interest Notice - R, page-8

re: Ann: Change of Director's Interest No... "BIT slightly more cash than ANP - 3 x drugs in Phase II and only valued a couple of million higher."

---

Bits problem is they are competing in highly contested markets...and they also seemed to haved missed the HCV bubble a year or two ago...not much licensing interest.

ANP had no problem attracting licensing interest however a few things have happened along the way which has raised some doubt about the future success of our programs.

If I read it correctly, the market might be more hesitant about the safety rather than the efficacy of our programs?????

It would be super awesome if one of the directors bought like $100k in one lick...though that would move the market too much...